In the latest example of how drugmakers are raising prices despite mounting public criticism, one firm increased the cost of a spray form of Ambien by 843%. The company’s CEO defended the move, saying this drug is for a “lifestyle” condition.
from WSJ.com: US Business https://ift.tt/2LbtDxW
via IFTTT
No comments:
Post a Comment